Study to Evaluate the Safety and Efficacy of Pradaxar for the Prevention of Venous Thromboembolism in the Mexican Population Undergoing Elective Total Hip or Knee Replacement Surgery

TerminatedOBSERVATIONAL
Enrollment

2

Participants

Timeline

Start Date

February 1, 2009

Primary Completion Date

January 1, 2010

Conditions
ThromboembolismArthroplasty, Replacement, Hip
Trial Locations (28)

Unknown

Boehringer Ingelheim Investigational Site 10, Distrito Federal

Boehringer Ingelheim Investigational Site 11, Distrito Federal

Boehringer Ingelheim Investigational Site 12, Distrito Federal

Boehringer Ingelheim Investigational Site 13, Distrito Federal

Boehringer Ingelheim Investigational Site 14, Distrito Federal

Boehringer Ingelheim Investigational Site 15, Distrito Federal

Boehringer Ingelheim Investigational Site 16, Distrito Federal

Boehringer Ingelheim Investigational Site 17, Distrito Federal

Boehringer Ingelheim Investigational Site 18, Distrito Federal

Boehringer Ingelheim Investigational Site 19, Distrito Federal

Boehringer Ingelheim Investigational Site 1, Distrito Federal

Boehringer Ingelheim Investigational Site 20, Distrito Federal

Boehringer Ingelheim Investigational Site 2, Distrito Federal

Boehringer Ingelheim Investigational Site 3, Distrito Federal

Boehringer Ingelheim Investigational Site 4, Distrito Federal

Boehringer Ingelheim Investigational Site 5, Distrito Federal

Boehringer Ingelheim Investigational Site 6, Distrito Federal

Boehringer Ingelheim Investigational Site 7, Distrito Federal

Boehringer Ingelheim Investigational Site 8, Distrito Federal

Boehringer Ingelheim Investigational Site 9, Distrito Federal

Boehringer Ingelheim Investigational Site 21, Guadalajara

Boehringer Ingelheim Investigational Site 22, Guadalajara

Boehringer Ingelheim Investigational Site 23, Guadalajara

Boehringer Ingelheim Investigational Site 24, Guadalajara

Boehringer Ingelheim Investigational Site 25, Guadalajara

Boehringer Ingelheim Investigational Site 28, Monterrey

Boehringer Ingelheim Investigational Site 26, Puebla City

Boehringer Ingelheim Investigational Site 27, Puebla City

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY